Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Neuroblastoma
Drug:
doxorubicin hydrochloride
(
Topoisomerase II inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Source:
FDA
Published date:
08/28/2020
Excerpt:
Doxorubicin Hydrochloride Injection/for Injection is an anthracycline topoisomerase inhibitor indicated...for the treatment of...metastatic neuroblastoma…
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login